Chronic Kidney Disease, Dialysis, and Transplantation E-Book

preview-18
  • Chronic Kidney Disease, Dialysis, and Transplantation E-Book Book Detail

  • Author : Jonathan Himmelfarb
  • Release Date : 2018-11-06
  • Publisher : Elsevier Health Sciences
  • Genre : Medical
  • Pages : 768
  • ISBN 13 : 0323531725
  • File Size : 57,57 MB

Chronic Kidney Disease, Dialysis, and Transplantation E-Book by Jonathan Himmelfarb PDF Summary

Book Description: Contains expanded content on economics and outcomes of treatment, as well as acute kidney injury. Covers hot topics such as the genetic causes of chronic kidney disease, ethical challenges and palliative care, and home hemodialysis. Discusses the latest advances in hypertensive kidney disease, vitamin D deficiency, diabetes management, transplantation, and more. Provides a clear visual understanding of complex information with high-quality line drawings, photographs, and diagnostic and treatment algorithms.

Disclaimer: www.yourbookbest.com does not own Chronic Kidney Disease, Dialysis, and Transplantation E-Book books pdf, neither created or scanned. We just provide the link that is already available on the internet, public domain and in Google Drive. If any way it violates the law or has any issues, then kindly mail us via contact us page to request the removal of the link.

Oxford Textbook of Clinical Nephrology

Oxford Textbook of Clinical Nephrology

File Size : 71,71 MB
Total View : 9455 Views
DOWNLOAD

This fourth edition of the Oxford Textbook of Clinical Nephrology builds on the success and international reputation of the publication as an important resource

Oxford Textbook of Clinical Nephrology

Oxford Textbook of Clinical Nephrology

File Size : 48,48 MB
Total View : 2570 Views
DOWNLOAD

Illustrated in full colour throughout, this comprehensive edition provides the reader with complete information on clinical and practical problems in nephrology

Biomarkers in Renal Disease

Biomarkers in Renal Disease

File Size : 95,95 MB
Total View : 890 Views
DOWNLOAD

Advances in long-term improvement and outcomes of patients with kidney disease will require the use of novel biomarkers to identify patients at high risk for ki